🟢 Outlook Therapeutics is trading 5% up today

Outlook Therapeutics is trading 5.02% up now at $0.67, with no clear company-specific, sector, or macro catalyst established.

• No new company-specific announcement dated September 15, 2026, was identified.
• The latest updates were a September 11 H.C. Wainwright fireside chat and a September 10 discussion of LYTENAVA’s FDA approval and planned U.S. launch; neither directly explains the move.
• Biotech and major indexes are lower.